Stephen D. Silberstein

Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) [RETIRED]

Stephen D. Silberstein · Neurology · 2000 · 1.4K citations · Full text

Life Sciences, Neurology, Pain Management +4

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program

David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse et al. · Headache The Journal of Head and Face Pain · 2010 · 986 citations

Medicine, Pharmacology, Pharmacotherapy +17

Fremanezumab for the Preventive Treatment of Chronic Migraine

Stephen D. Silberstein, David W. Dodick, Marcelo E. Bigal et al. · New England Journal of Medicine · 2017 · 803 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial

Stewart J. Tepper, Messoud Ashina, Uwe Reuter et al. · The Lancet Neurology · 2017 · 735 citations

Medicine, Neurology, Pharmacology +9

Classification of daily and near-daily headaches

Stephen D. Silberstein, Richard B. Lipton, Martin J. Sliwinski · Neurology · 1996 · 615 citations

Medicine, Neurology, Manual Therapy +11